Discovery of a potent dual SLK/STK10 inhibitor based on a maleimide scaffold

Discovery of a potent dual SLK/STK10 inhibitor based on a maleimide scaffold

SLK (STE20-like kinase) and STK10 (serine/threonine kinase 10) are closely related kinases whose enzymatic activity is linked to the regulation of ezrin, radixin, and moesin function and to the regulation of lymphocyte migration and the cell cycle. We identified a series of 3-anilino-4-arylmaleimide...

Bibliográfalaš dieđut
Váldodahkkit:	Serafim, RAM, Sorrell, FJ, Berger, B-T, Collins, RJ, Vasconcelos, SNS, Massirer, KB, Knapp, S, Bennett, J, Fedorov, O, Patel, H, Zuercher, WJ, Elkins, JM
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	American Chemical Society 2021

Geahča maid

Design and analysis of the 4-anilino-quin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure activity relationships
Dahkki: Asquith, C, et al.
Almmustuhtton: (2019)

Chemical probes for understudied kinases: challenges and opportunities
Dahkki: Serafim, RAM, et al.
Almmustuhtton: (2021)

A challenging Heck reaction of maleimides
Dahkki: Lim, Li Hui, et al.
Almmustuhtton: (2018)

Peptide and enzyme catalyzed Michael addition to maleimides
Dahkki: Paton, R, et al.
Almmustuhtton: (2010)

Polymerization of maleimides and maleic anhydride initiated by triphenylphosphine /
Dahkki: 293856 Hodge, Philip, et al.

Dissecting non-covalent interactions in oxazaborolidinium catalyzed cycloadditions of maleimides.
Dahkki: Paton, R
Almmustuhtton: (2014)

Report on industrial attachment with Singapore Technologies Kinetics (STK)
Dahkki: Wong, Ee Yin.
Almmustuhtton: (2008)

Mass spectrometric analysis of maleimide CyDye labelled model peptides.
Dahkki: Wheeler, J, et al.
Almmustuhtton: (2003)

Structural and thermal characterizations of silica nanoparticles grafted with pendant maleimide and epoxide groups
Dahkki: P Vejayakumaran, et al.
Almmustuhtton: (2008)

Monovalent Maleimide Functionalization of Gold Nanoparticles Via Copper-Free Click Chemistry
Dahkki: D. J., Nieves, et al.
Almmustuhtton: (2014)

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
Dahkki: Huber, K, et al.
Almmustuhtton: (2012)

Pharmacological targeting of STK19 inhibits oncogenic NRAS-driven melanomagenesis
Dahkki: Yin, C, et al.
Almmustuhtton: (2019)

Arachidonic acid-induced LH release is ATP-independent and insensitive to N-ethyl maleimide.
Dahkki: Kaye, P, et al.
Almmustuhtton: (1992)

Genotyping for polymorphism of STK-15, a low-penetrance gene in colorectal cancer
Dahkki: Ng, Chen Seng
Almmustuhtton: (2008)

Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients.
Dahkki: Wang, Z, et al.
Almmustuhtton: (1999)

The role of LKB1 (STK11) in non-small cell lung cancer
Dahkki: Cahill, F
Almmustuhtton: (2017)

Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors.
Dahkki: Profeta, GS, et al.
Almmustuhtton: (2019)

Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.
Dahkki: Lim, W, et al.
Almmustuhtton: (2003)

Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors
Dahkki: Atkinson, BN, et al.
Almmustuhtton: (2019)

N-(2-ferrocene-ethyl)maleimide: a new electroactive sulphydryl-specific reagent for cysteine-containing peptides and proteins.
Dahkki: Di Gleria, K, et al.
Almmustuhtton: (1996)

STK15 Phe31Ile and Val57Ile Polymorphisms Increase the Risk of Gastrointestinal Cancer
Dahkki: Lai, Tianxin, et al.
Almmustuhtton: (2018)

Variants of LYST and novel STK4 gene mutation in a child with accelerated Chediak Higashi syndrome
Dahkki: Abu Bakar, Asrar, et al.
Almmustuhtton: (2024)

STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
Dahkki: Luo, Tuoping, et al.
Almmustuhtton: (2012)

Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Dahkki: Scholl, Claudia, et al.
Almmustuhtton: (2015)

In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours.
Dahkki: Rowan, A, et al.
Almmustuhtton: (2000)

Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer
Dahkki: Scott, F, et al.
Almmustuhtton: (2020)

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
Dahkki: Bataille, C, et al.
Almmustuhtton: (2017)

Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
Dahkki: Hewings, D, et al.
Almmustuhtton: (2013)

OPTIMASI SUMBER KARBON DAN KONDISI FERMENTASI PRODUKSI SELULOSA OLEH STRAIN BAKTERI Acetobacter lovaniensis (MGA 6, SLK 1) DAN Gluconobacter oxidans (GDN 32)
Dahkki: , RISA UMAMI, et al.
Almmustuhtton: (2012)

Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2
Dahkki: Moustakim, M, et al.
Almmustuhtton: (2018)

Expression of STK15, CENPW and TIMP1 genes in breast and colorectal cancers from human blood samples
Dahkki: Goh, Lucky Poh Wah
Almmustuhtton: (2015)

Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome.
Dahkki: Hearle, N, et al.
Almmustuhtton: (2005)

Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
Dahkki: Yu, W, et al.
Almmustuhtton: (2013)

Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
Dahkki: Yu, W, et al.
Almmustuhtton: (2013)

High-Volume-Fraction Textured Carbon Nanotube-Bis(maleimide) and -Epoxy Matrix Polymer Nanocomposites: Implications for High-Performance Structural Composites
Dahkki: Kaiser, Ashley L, et al.
Almmustuhtton: (2022)

Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
Dahkki: Sorrell, F, et al.
Almmustuhtton: (2019)

Identification of a novel mRNA species of the LKB1/STK11 Peutz-Jeghers serine/threonine kinase.
Dahkki: Churchman, M, et al.
Almmustuhtton: (1999)

Structure of dystrophia myotonica protein kinase.
Dahkki: Elkins, J, et al.
Almmustuhtton: (2009)

Structure of dystrophia myotonica protein kinase.
Dahkki: Elkins, J, et al.
Almmustuhtton: (2009)

Development of pyridine-based inhibitors for the human vaccinia-related kinases 1 and 2
Dahkki: Serafim, R, et al.
Almmustuhtton: (2019)